Vertically integrated cannabis company Cansortium Inc. TIUM CNTMF, which operates under the Fluent brand, announced its fourth-quarter and full-year 2020 financial results Monday.
The Miami-based company generated $14.7 million in consolidated revenue during the three months ending Dec. 31, marking a 54% year-over-year increase.
"Our strong fourth-quarter results reflect the many improvements we have made across the organization, and that momentum has carried into 2021," CEO Robert Beasley said in a statement.
Cansortium's Q4 Highlights
- Florida revenue spiked 43% year-over-year to $12.8 million.
- Consolidated loss from operations amounted to $8.4 million versus a $32.8-million loss in the corresponding quarter of 2020.
- Consolidated adjusted EBITDA grew to $3.3 million versus $100,000 for the same period of 2019.
Cansortium's 2020 Financial Highlights
- Consolidated revenue rose 84% year-over-year to $52.4 million.
- Florida revenue amounted to $46.4 million compared to $25.1 million in 2019.
- Consolidated loss from operations was $36.6 million versus a $65.6-million loss in the year before.
- Consolidated adjusted EBITDA grew to $10.3 million versus an adjusted EBITDA loss of $6.9 million in 2019.
In April, Cansortium saw record monthly sales in Florida, reaching roughly $5 million, following the launch of a Sweetwater cultivation facility, said Beasley, who became CEO in September ahead of joining the company's board of directors in January.
"In Pennsylvania, we also achieved record first-quarter revenues of more than $2 million and expect to have our second dispensary in Mechanicsburg open in July and have identified a location for our third dispensary, which we expect to open in the fourth quarter," he said.
Cansortium recently raised some $12 million via a sale of approximately 17.14 million of its units at 70 cents per unit to boost its operations in Florida, Michigan and Pennsylvania.
The company expects to generate between $90 million to $100 million in revenue in 2021 and achieve an adjusted EBITDA of approximately $30 million to $35 million.
CNTMF Price Action: Cansortium shares were down 10.28% at 96 cents at the close Tuesday.
Photo Source: CNW Group/Cansortium Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.